Drugs / pCCLchimGp91s
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01381003 | Nov 2011 → Nov 2016 | granulomatous disease, chronic, X-linked | Great Ormond Street Hospital for Children NHS Foundation Trust | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | pCCLchimGp91s | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01381003 ↗ |
| Action | Restore | “introducing a normal copy of human gp91-phox gene into the blood forming stem cells” NCT01381003 ↗ |
| Route | Intravenous | “pCCLchimGp91s lentiviral vector transduced CD34+ cells will be infused in a volume of 50-100 mls intravenously over 30-45 minutes” NCT01381003 ↗ |